Efficacy and safety of long-acting risperidone injection after switching from antipsychotics in Chinese patients

被引：0
|
作者：
Li, H. F. [1 ]
Gu, N. F. [1 ]
Zhou, M. [2 ]
Jia, F. J. [3 ]
Zhao, Z. H. [4 ]
Fan, J. X. [5 ]
Wang, G. [6 ]
Sun, X. L. [7 ]
Li, M. [8 ]
Zhang, J. B. [9 ]
机构：
[1] Shanghai Mental Hlth Ctr, Shanghai, Peoples R China
[2] Beijing Univ, Mental Hlth Inst, Beijing, Peoples R China
[3] Guangdong Mental Hlth Inst, Guangdong, Peoples R China
[4] GuangZhou Brain Hosp, Guangdong, Peoples R China
[5] Nanjing Brain Hosp, Dept Psychiat, Nanjing, Peoples R China
[6] Beijing Anding Hosp, Beijing, Peoples R China
[7] Sichuan Huaxi Hosp, Dept Psychiat, Chengdu, Peoples R China
[8] SuZhou Guangji Hosp, Suzhou, Peoples R China
[9] Zhongshan Univ, Affiliated Hosp 3, Guangdong, Peoples R China
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2007年 / 17卷
关键词：
D O I：
10.1016/S0924-977X(07)70606-5
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S405 / S406
页数：2
相关论文
共 50 条
  • [1] A study of the efficacy and safety of switching from oral risperidone to risperidone long-acting injection in older patients with schizophrenia
    Suzuki, Hidenobu
    Inoue, Yuichi
    Gen, Keishi
    THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 2012, 2 (06) : 227 - 234
  • [2] Risperidone Long-Acting Injection: Safety and Efficacy in Elderly Patients with Schizophrenia
    Catalan, Rosa
    Penades, Rafael
    JOURNAL OF CENTRAL NERVOUS SYSTEM DISEASE, 2011, 3 : 95 - 105
  • [3] Long-acting injectable risperidone safety and efficacy in patients switched from conventional depot antipsychotics
    Turner, M
    Eerdekens, M
    Jacko, M
    SCHIZOPHRENIA RESEARCH, 2003, 60 (01) : 305 - 305
  • [4] Switching stable patients with schizophrenia from depot and oral antipsychotics to long-acting injectable risperidone: reasons for switching and safety
    Hawley, Chris
    Turner, Martin
    Latif, Muhammud A.
    Curtis, Vivienne
    Saleem, Packeruther T.
    Wilton, Kristina
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2010, 25 (01) : 37 - 46
  • [5] Long-acting injectable risperidone: safety and efficacy in stable patients switched from conventional depot antipsychotics
    Turner, M
    Eerdekens, E
    Jacko, M
    Eerdekens, M
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2004, 19 (04) : 241 - 249
  • [6] Efficacy and safety of risperidone long-acting injection in elderly people with schizophrenia
    Singh, Dhiren
    O'Connor, Daniel W.
    CLINICAL INTERVENTIONS IN AGING, 2009, 4 : 351 - 355
  • [7] Risperidone long-acting injectable improves efficacy and safety in schizophrenic patients after changing from oral risperidone
    Kusters, J
    Glue, P
    Katsafouros, K
    Boon, H
    Medori, R
    Parellada, E
    EUROPEAN PSYCHIATRY, 2005, 20 : S79 - S79
  • [8] Efficacy and safety of long-acting injectable risperidone in patients with schizophrenia
    Bouhours, P
    Schreiner, A
    Rendall, MR
    SCHIZOPHRENIA RESEARCH, 2004, 67 (01) : 170 - 171
  • [9] Long-acting injectable risperidone: Efficacy and safety
    Kane, JM
    Eerdekens, M
    Keith, SJ
    Lesem, M
    Karcher, K
    Lindenmayer, JP
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S325 - S325
  • [10] Long-acting risperidone, efficacy and safety of a new risperidone formulation
    Chinchilla, A
    Vega, M
    Quintero, J
    Yañez, R
    Correas, J
    Crespo, D
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S238 - S238
12345